Plandai Biotechnology, Inc. (PLPL) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 13 transactions totaling $147.0K, demonstrating a bearish sentiment with -$147.0K in net insider flow. The most recent transaction on Feb 5, 2014 involved a transaction of 2,036,000 shares valued at $509.0K.
No significant insider buying has been recorded for PLPL in the recent period.
No significant insider selling has been recorded for PLPL in the recent period.
Based on recent SEC filings, insider sentiment for PLPL is bearish with an Insider Alignment Score of 0/100 and a net flow of -$147.0K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Plandai Biotechnology, Inc. (PLPL) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading PLPL stock, having executed 13 transactions in the past 90 days. The most active insider is Roger Duffield (Executive), who has made 5 transactions totaling $1.2M.
Get notified when executives and directors at PLPL file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 5, 2014 | Duffield Roger | Executive | Conversion | 2,036,000 | $0.25 | $509.0K | Large |
| Jan 1, 2014 | Baylis Duffield Daron | Executive | Award | 240,000 | $0.06 | $14.4K | |
| Jan 1, 2014 | Baylis-duffield Callum | Executive | Award | 1,000,000 | $0.06 | $60.0K | |
| Jan 1, 2014 | Rzepnicki David | Executive | Award | 500,000 | $0.60 | $300.0K | |
| Jan 1, 2014 | Johnson Brian | Executive | Award | 240,000 | $0.06 | $14.4K | |
| Feb 15, 2013 | Duffield Roger | Executive | Award | 2,000,000 | $0.12 | $240.0K | |
| Feb 7, 2013 | Matula Timothy | Executive | Sale | 4,900,000 | $0.03 | $147.0K | |
| Jan 1, 2013 | Duffield Roger | Executive | Award | 2,000,000 | $0.12 | $240.0K | |
| Apr 11, 2012 | Duffield Roger | Executive | Award | 10,500 | $0.22 | $2.3K | |
| Mar 30, 2012 | Johnson Brian | Executive | Award | 1,500,000 | $0.23 | $345.0K | |
| Mar 8, 2012 | Duffield Roger | Executive | Award | 803,400 | $0.32 | $257.1K | |
| Mar 8, 2012 | Baylis Duffield Daron | Executive | Award | 450,000 | $0.32 | $144.0K | |
| Mar 8, 2012 | Rzepnicki David | Executive | Award | 150,000 | $0.06 | $9.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 11 | $1.6M | 71.3% |
Conversion(C) | 1 | $509.0K | 22.3% |
Sale(S) | 1 | $147.0K | 6.4% |
Insider selling pressure at Plandai Biotechnology, Inc. has increased, with 6 insiders executing 13 transactions across all time. Total sales of $147.0K significantly outpace purchases of $0, resulting in a net outflow of $147.0K. This selling activity appears largely discretionary, which may warrant closer attention from investors.